• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

18
3
3
3
1

COUNTRY

3
1

PRICE

8
10
32
43

PUBLISHED

0
2
3
43

PRODUCT TYPE

42
1

Ovarian Cancer

Far less common than breast cancer, but with a higher mortality rate, sufferers of ovarian cancer are experiencing significant unmet needs. There are therefore considerable market opportunities for drug designers and manufacturers in this life-saving sector of the pharmaceutical industry. In this section a host of cutting edge reports provide valuable insight into key markets such as China and the US, the latest drug development activities and the market trends (including sales, pricing and forecasts) for specific drugs like Doxil, Caelyx, Yondelis and Paclitaxel. You can also purchase reports that feature the latest strategies of major and niche industry players such as Alza Corporation, Amgen, Bristol-Myers Squibb, Cell Therapeutics, Genentech, GlaxoSmithKline, Immunogen, Ivax, OSI Pharmaceuticals and Raven Biotechnologies.
Show Less
Read more

PRODUCT TITLE

Global Ovarian Cancer Market 2014-2018

About Ovarian Cancer and its therapy Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological...

June 2014
FROM

Ovarian Cancer Treatment Drugs Markets in China

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM

Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies

The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carboplatin and paclitaxel, which are used in combination for the treatment of platinum-sensitive disease...

May 2014
FROM
Disease and Therapy Review: Ovarian Cancer Disease and Therapy Review: Ovarian Cancer - Product Thumbnail Image

Disease and Therapy Review: Ovarian Cancer

The Ovarian Cancer Disease and Therapy Review provides an overview of ovarian cancerm, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, as well as information...

August 2013
FROM
Disease and Therapy Review: Ovarian Cancer Disease and Therapy Review: Ovarian Cancer - Product Thumbnail Image

Disease and Therapy Review: Ovarian Cancer

The Ovarian Cancer Disease and Therapy Review provides an overview of ovarian cancerm, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, as well as information...

August 2013
FROM

Ovarian Cancer Pipeline Analysis

“Ovarian Cancer Pipeline Analysis” gives a comprehensive insight into the various drug profiles being developed for the treatment of Ovarian Cancer This research report covers all the ongoing drug development...

August 2013
FROM
Global Ovarian Cancer Pipeline Capsule - 2013 Global Ovarian Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Ovarian Cancer Pipeline Capsule - 2013

Fore Pharma's latest report ‘Global Ovarian Cancer Pipeline Capsule – 2013' provides up-to-date information on key Research and Development (R&D) activities in the global ovarian cancer market It covers...

April 2013
FROM
Metastatic Ovarian Cancer - Pipeline Review, H2 2012 Metastatic Ovarian Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Metastatic Ovarian Cancer - Pipeline Review, H2 2012

Metastatic Ovarian Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

October 2012
FROM
Ovarian Cancer - Pipeline Review, H2 2012 Ovarian Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H2 2012

Ovarian Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2012
FROM
09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012 All companies include technology, market(s), key...

September 2012
FROM
Global Ovarian Cancer Drugs Market 2011-2015 Global Ovarian Cancer Drugs Market 2011-2015 - Product Thumbnail Image

Global Ovarian Cancer Drugs Market 2011-2015

TechNavio's analysts forecast the Global Ovarian Cancer Drugs market to grow at a CAGR of 13 1 percent over the period 2011-2015 One of the key factors contributing to this market growth is the increasing...

August 2012
FROM
06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012 All companies include technology, market(s), key executive,...

June 2012
FROM
05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 41 emerging medical technology companies that have been identified by LSI's in-house research team in May 2012 All companies include technology, market(s), key executive,...

May 2012
FROM
04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 37 emerging medical technology companies that have been identified by LSI's in-house research team in April 2012 All companies include technology, market(s), key executive,...

April 2012
FROM
03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 61 emerging medical technology companies that have been identified by LSI's in-house research team in March 2012 All companies include technology, market(s), key executive,...

March 2012
FROM
02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 43 emerging medical technology companies that have been identified by LSI's in-house research team in February 2012 All companies include technology, market(s), key executive,...

February 2012
FROM

Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020

Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Doxil/Caelyx sales...

January 2012
FROM
Global Ovarian Cancer Drug Pipeline Capsule - 2012 Global Ovarian Cancer Drug Pipeline Capsule - 2012 - Product Thumbnail Image

Global Ovarian Cancer Drug Pipeline Capsule - 2012

Fore Pharma’s latest report ‘Global Ovarian Cancer Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global ovarian cancer drug market. It covers...

January 2012
FROM
01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 47 emerging medical technology companies that have been identified by LSI's in-house research team in January 2012 All companies include technology, market(s), key executive,...

January 2012
FROM

Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020

Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Yondelis sales forecasts...

September 2011
FROM
Loading Indicator

Our Clients

Our clients' logos